Itraconazol-suba at the X National Congress of Medical Mycology Organized by the Mexican Association of Medical Mycology, A.C., on Oaxtepec, Morelos, from October 10 to 12, 2019

2019, Number 4

Dermatología Cosmética, Médica y Quirúrgica 2019; 17 (4)

Language: Spanish
References: 4
Page: 305-305
PDF size: 54.67 Kb.

Text Extraction

No abstract.

REFERENCES

De Doncker P, Pande S, Richarz U y Garodia N, Itraconazole: what clinicians should know?, Indian J Drugs Dermatol 2017; 3:4-10.
Lindsay J, Mudge S, Thompson GR et al., Effects of food and omeprazole on novel formulation suba-itraconazole in healthy subjects, Antimicrobial Agents and Chemotherapy 2018; 62(12): pii e011723.
Lindsay J, Sandaradura I, Wong K et al., Serum levels, safety and tolerability of new formulation suba-itraconazole prophylaxis in patients with haematological malignancy or undergoing allogeneic stem cell transplantation, J Antimicrob Chemother 2017; 72(12):3414-9.
Pan Pantziarka P, Sukhatme V, Bouche G, Meheus L y Sukhatme VP, Repurposing Drugs in Oncology (redo): itraconazole as an anti-cancer agent, Cancer 2015; 9:521.